Zhong Nanshan was awarded the title of one of the first batch of national-level experts with outstanding contributions in 1984. Served as graduate tutor in 1985.In 1995, he became a doctoral supervisor. In May 1996, he was elected as an academician of the Chinese Academy of Engineering. Zhong became president of the
Chinese Thoracic Society in 2000 and became president of the
Chinese Medical Association in 2005. He is currently the director of the Guangzhou Institute of Respiratory Diseases and editor-in-chief of the
Journal of Thoracic Disease.
SARS outbreak When Zhong directed the
Guangzhou Institute of Respiratory Diseases, they received the second case of a
SARS patient as early as 20 December 2002. Over the next month, 28 similar cases were reported in
Zhongshan alone, and on 21 January 2003, Zhong and other doctors and researchers in related fields reported this disease at an emergency meeting and gave it the name
atypical pneumonia. On 28 January 2003, Zhong felt sick and discovered that he had caught
pneumonia. Concerned that the news that a leading researcher and doctor for respiratory diseases falling ill during the SARS outbreak would cause fear and panic for the general public, Zhong decided to not receive treatment in the hospital. Instead he returned home, hoping that it was not caused by SARS and that he could recover without treatment. With care from his wife,
Li Shaofen, he managed to recover after eight days. After recovery he immediately returned to the Guangzhou Institute of Respiratory Diseases to direct the fight against SARS. On 11 February 2003, at a press conference held by the
Guangdong Department of Health, Zhong explained the disease and its symptoms, and calmed the public by asserting that it was "preventable" and "curable". that authorities in Wuhan were likely understating the severity of the outbreak, and on the same day, publicly announced on state television the same. During the pandemic, Zhong had promoted publicly the usage of a controversial traditional Chinese medicine of
Lianhua Qingwen capsule for treating COVID-19 infection. Though later he had denied any commercial tie with the pharmaceutical company that supplies the capsule, on 4 May 2021, an article from
Retraction Watch showed that Zhong and his coworkers were financially tied to the Yiling Pharmaceutical company that supplies the capsule. In 2020, Zhong worked with
Tencent to establish an AI Joint Lab to conduct research on disease screening, prevention, and outbreak warnings. Zhong also worked on pandemic research projects with
Foxconn and
Alibaba Cloud. == Honors ==